126 related articles for article (PubMed ID: 27925687)
21. Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma.
Sá MC; Conceição TS; de Moura Santos E; de Morais EF; Galvão HC; de Almeida Freitas R
Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):893-902. PubMed ID: 31828418
[TBL] [Abstract][Full Text] [Related]
22. DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.
Shaikh AY; Martin LJ
Neuromolecular Med; 2002; 2(1):47-60. PubMed ID: 12230304
[TBL] [Abstract][Full Text] [Related]
23. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features.
Po Wing Yuen A; Lam KY; Lam LK; Ho CM; Wong A; Chow TL; Yuen WF; Wei WI
Head Neck; 2002 Jun; 24(6):513-20. PubMed ID: 12112547
[TBL] [Abstract][Full Text] [Related]
25. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.
Knopf A; Lempart J; Bas M; Slotta-Huspenina J; Mansour N; Fritsche MK
Oncotarget; 2015 Feb; 6(5):3443-51. PubMed ID: 25633809
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in genes implicated in base excision repair (BER) pathway are associated with susceptibility to Paget's disease of bone.
Usategui-Martín R; Gutiérrez-Cerrajero C; Jiménez-Vázquez S; Calero-Paniagua I; García-Aparicio J; Corral-Gudino L; Del Pino-Montes J; González-Sarmiento R
Bone; 2018 Jul; 112():19-23. PubMed ID: 29630930
[TBL] [Abstract][Full Text] [Related]
27. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases.
Rodrigues PC; Miguel MC; Bagordakis E; Fonseca FP; de Aquino SN; Santos-Silva AR; Lopes MA; Graner E; Salo T; Kowalski LP; Coletta RD
Int J Oral Maxillofac Surg; 2014 Jul; 43(7):795-801. PubMed ID: 24583139
[TBL] [Abstract][Full Text] [Related]
29. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
30. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
31. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
[TBL] [Abstract][Full Text] [Related]
32. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
35. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival.
Durr ML; van Zante A; Li D; Kezirian EJ; Wang SJ
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):89-96. PubMed ID: 23533221
[TBL] [Abstract][Full Text] [Related]
36. Loss of PTEN expression as a prognostic marker for tongue cancer.
Lee JI; Soria JC; Hassan KA; El-Naggar AK; Tang X; Liu DD; Hong WK; Mao L
Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1441-5. PubMed ID: 11735811
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
38. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
Ling W; Mijiti A; Moming A
J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
[TBL] [Abstract][Full Text] [Related]
39. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome.
Soudry E; Preis M; Hod R; Hamzany Y; Hadar T; Bahar G; Strenov Y; Shpitzer T
Clin Otolaryngol; 2010 Aug; 35(4):307-12. PubMed ID: 20738340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
